HIV phylogenetics, the study of viral genetic sequences, is used to track the spread of different viral lineages, and to identify likely transmission events, chains and clusters. Phylogenetics enhances HIV prevention science by quantifying the risk factors for onwards transmission, resolving epidemics into sub-epidemics, and identifying common routes of transmission. In discordant pair studies, such as HPTN 052, phylogenetics is used to determine whether transmission events could or could not have occurred within the studied couple. This increases the power and accuracy of such studies.
In concentrated epidemics, such as amongst MSM in Europe, phylogenetics has been used to characterize transmission patterns. After reviewing key results in the area, I will focus on recent phylogenetic studies conducted in the Netherlands, where the epidemic amongst MSM has been increasing in recent years. We determined the characteristics and dynamics of different transmission clusters, and found that the epidemic was diffuse, with a large number of clusters sharing similar dynamics. We find that the epidemic is continuously replenished by the formation of new clusters amongst younger individuals. Next, by zooming in on probable transmission pairs, we quantified transmission rates throughout the stages of infection, starting from acute infection and through the different stages of the care and treatment continuum. We found that HIV prevention requires a combination of improvements in take-up of testing, speedy treatment initiation, and rapid viral suppression.
I will conclude by describing next-generation sequencing data from different settings. Here, the whole viral genome is reconstructed, and a measure of diversity within samples is also obtained. Dual infection can be identified with relative ease, and is observed in all studied populations. These techniques yield large increases in phylogenetic resolution, such that sub-epidemics can be more clearly delineated. I will describe how phylogenetics is becoming part of the standard toolkit of HIV prevention studies.
All work described is joint work with the HIV Monitoring Foundation in Amsterdam, the BEEHIVE collaboration, the PANGEA-HIV consortium, the HPTN 071 study team, and my research group at Imperial College.